Taspoglutide
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
Roche · Phase 3 · Completed · Enrollment 305
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| placebo | n/r | n/r | n/r | n/r |
| taspoglutide | n/r | n/r | n/r | n/r |
Not shown
- placebo: endpoint not reported
- taspoglutide: endpoint not reported